SWK Holdings Corporation (SWKH) 10-Year Financial Performance & Capital Metrics

SWKH • • Banking & Credit

Financial ServicesAsset ManagementSpecialized & Niche Asset ManagersSector & Commodity Specialists

AboutSWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.Show more

Net Interest Income -$5M -153.4%
Total Revenue $45M +19.1%
Net Income $13M -15.1%
Return on Equity 4.74% -16.4%
Net Interest Margin -1.41% -154.9%
Efficiency Ratio 69.35% +33.1%
ROA 4.05% -19.3%
Equity / Assets 86.89% +3.6%
Book Value per Share 23.19 +5.0%
Tangible BV/Share 23.19 +7.5%
Debt/Equity 0.13 -15.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9
✓Well capitalized: 86.9% equity/assets
✓Diversified revenue: 100.0% from non-interest income
✓Trading near 52-week high
✓Trading at only 0.8x book value

✗Weaknesses

✗Profits declining 10.8% over 5 years
✗Weak NIM of -1.4%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.96%

5Y7.91%

3Y-7.12%

TTM-

Profit (Net Income) CAGR

10Y-4.22%

5Y-10.76%

3Y-19.58%

TTM117.28%

EPS CAGR

10Y-10.29%

5Y-10.21%

3Y-18.84%

TTM99.2%

ROCE

10Y Avg6.32%

5Y Avg5.43%

3Y Avg3.91%

Latest3.53%

Peer Comparison

Sector & Commodity Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NHICNewHold Investment Corp III	216.79M	10.37	515.92			1.6%
PLTSPlatinum Analytics Cayman Limited Class A Ordinary Shares	196.1M	17.50	245.10	280.21%	35.16%
SOLSSolstice Advanced Materials Inc.	9.6B	60.51	22.75	3.32%	11.19%	13.59%	5.68%	0.13
HQLTekla Life Sciences Investors	491.34M	16.60	21.01	23.61%	56.75%	-13.43%
SWKHSWK Holdings Corporation	211.44M	17.48	16.19	19.14%	29.98%	8.94%	10.84%	0.13
BURBurford Capital Limited	2.15B	9.83	14.89	-56.23%	31.02%	2.7%	10.04%	0.55
ASAASA Gold and Precious Metals Limited	1.2B	63.48	10.48	9.47%	96.94%	39.78%
STKESol Strategies Inc. Common Shares	64.53M	2.30	7.19			-4.25%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Interest Income+	-381K	15.84M	0	-160K	-338K	-455K	-374K	-340K	-1.85M	-4.68M
NII Growth %	0.33%	42.57%	-1%	-	-1.11%	-0.35%	0.18%	0.09%	-4.44%	-1.53%
Net Interest Margin %	-	-	-	-	-	-	-	-	-	-
Interest Income	0	15.84M	0	0	0	0	0	0	0	0
Interest Expense	381K	0	0	160K	338K	455K	374K	340K	1.85M	4.68M
Loan Loss Provision	-371K	0	0	0	838K	3.81M	6.97M	6.61M	1.59M	-2.48M
Non-Interest Income+	23.46M	6.54M	37.49M	0	30.75M	36.71M	56.16M	41.48M	37.76M	44.99M
Non-Interest Income %	-	-	-	-	-	-	-	-	-	-
Total Revenue+	23.46M	22.38M	37.49M	0	30.75M	36.71M	56.16M	41.48M	37.76M	44.99M
Revenue Growth %	0.35%	-0.05%	0.67%	-1%	-	0.19%	0.53%	-0.26%	-0.09%	0.19%
Non-Interest Expense	14.23M	4.49M	4.1M	-6.4M	14.59M	22.64M	17.77M	24.56M	19.67M	31.2M
Efficiency Ratio	-	-	-	-	-	-	-	-	-	-
Operating Income+	2.6M	17.89M	33.38M	6.24M	14.98M	9.81M	31.04M	9.97M	14.65M	11.59M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.82%	5.89%	0.87%	-0.81%	1.4%	-0.35%	2.17%	-0.68%	0.47%	-0.21%
Pretax Income+	-1.09M	10.4M	24M	6.24M	16.84M	3.67M	33.01M	9.49M	14.61M	18.37M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	3.27M	-21.64M	15.75M	42K	-6.99M	-1.54M	7.08M	-4M	-1.27M	4.88M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	-7.37M	28.89M	3.05M	6.2M	23.83M	5.2M	25.93M	13.49M	15.89M	13.49M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-1.35%	4.92%	-0.89%	1.03%	2.85%	-0.78%	3.98%	-0.48%	0.18%	-0.15%
Net Income (Continuing)	-4.36M	32.04M	8.25M	6.2M	23.83M	5.2M	25.93M	13.49M	15.89M	13.49M
EPS (Diluted)+	-0.57	2.22	0.23	0.47	1.85	0.40	2.02	1.05	1.25	1.08
EPS Growth %	-1.18%	4.89%	-0.9%	1.04%	2.94%	-0.78%	4.05%	-0.48%	0.19%	-0.14%
EPS (Basic)	-0.57	2.22	0.23	0.47	1.85	0.40	2.03	1.05	1.26	1.09
Diluted Shares Outstanding	12.99M	13.02M	13.04M	13.05M	12.91M	12.86M	12.83M	12.88M	12.7M	12.45M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash & Short Term Investments+	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Cash & Due from Banks	47.29M	32.18M	30.56M	20.23M	11.16M	3.01M	42.86M	6.16M	4.5M	5.93M
Short Term Investments	0	0	0	0	1000K	1000K	1000K	0	0	0
Total Investments+	13.27M	9.61M	1.86M	532K	2.27M	4.94M	4.64M	76K	48K	580K
Investments Growth %	-0.04%	-0.28%	-0.81%	-0.71%	3.26%	1.18%	-0.06%	-0.98%	-0.37%	11.08%
Long-Term Investments	13.27M	9.61M	1.86M	532K	466K	3.73M	3.61M	76K	48K	580K
Accounts Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Goodwill & Intangibles+	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	8.4M	8.4M	8.4M	8.4M	0	0
Intangible Assets	0	127.42M	153.63M	0	25.11M	13.45M	9.96M	8.19M	6.49M	0
PP&E (Net)	0	-38.47M	-22.73M	25K	1.29M	5.21M	5.78M	5.84M	5.44M	48K
Other Assets	2.62M	1.25M	1.11M	169.86M	177.02M	208.94M	186.94M	242.27M	282.12M	287.87M
Total Current Assets	147.76M	159.6M	184.19M	22.56M	16.3M	6.67M	47.43M	10.36M	11.87M	20.25M
Total Non-Current Assets	32.73M	49.33M	25.69M	193.1M	238.07M	267.23M	235.24M	289.26M	322.38M	311.98M
Total Assets+	180.49M	208.93M	209.88M	215.66M	254.37M	273.9M	282.67M	299.62M	334.25M	332.24M
Asset Growth %	-0.04%	0.16%	0%	0.03%	0.18%	0.08%	0.03%	0.06%	0.12%	-0.01%
Return on Assets (ROA)	-0.04%	0.15%	0.01%	0.03%	0.1%	0.02%	0.09%	0.05%	0.05%	0.04%
Accounts Payable	241K	0	0	2.58M	3.06M	3.65M	5.09M	0	0	0
Total Debt+	259K	189K	91K	0	0	11.76M	8K	2.44M	43.13M	37.65M
Net Debt	-47.03M	-31.99M	-30.47M	-20.23M	-11.16M	8.75M	-42.85M	-3.71M	38.63M	31.72M
Long-Term Debt	0	0	0	0	0	0	0	0	43.13M	37.65M
Short-Term Debt	0	0	0	0	0	11.76M	8K	2.44M	0	0
Other Liabilities	0	0	0	24K	14.78M	17.98M	10.33M	13.35M	6.86M	335K
Total Current Liabilities	788K	682K	1.84M	2.58M	3.06M	15.41M	5.09M	6.35M	3.94M	5.57M
Total Non-Current Liabilities	259K	189K	91K	24K	14.78M	17.98M	10.33M	13.35M	49.99M	37.98M
Total Liabilities	1.05M	871K	1.93M	2.6M	17.84M	33.39M	15.43M	19.69M	53.94M	43.55M
Total Equity+	179.44M	208.06M	177.4M	213.06M	236.53M	240.51M	267.24M	279.93M	280.31M	288.69M
Equity Growth %	-0.04%	0.16%	-0.15%	0.2%	0.11%	0.02%	0.11%	0.05%	0%	0.03%
Equity / Assets (Capital Ratio)	-	-	-	-	-	-	-	-	-	-
Return on Equity (ROE)	-0.04%	0.15%	0.02%	0.03%	0.11%	0.02%	0.1%	0.05%	0.06%	0.05%
Book Value per Share	13.82	15.98	13.60	16.32	18.32	18.70	20.82	21.73	22.08	23.19
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-
Common Stock	13K	13K	13K	13K	13K	13K	13K	12K	12K	12K
Additional Paid-in Capital	4.43B	4.43B	4.43B	4.43B	4.43B	4.43B	4.43B	4.43B	4.43B	4.42B
Retained Earnings	-4.26B	-4.23B	-4.23B	-4.22B	-4.2B	-4.19B	-4.16B	-4.15B	-4.14B	-4.13B
Accumulated OCI	0	-87K	213K	0	0	0	0	0	0	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Preferred Stock	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	11.21M	9.64M	19.46M	19.63M	18.54M	19.27M	34.3M	8.2M	14.89M	23.05M
Operating CF Growth %	1.19%	-0.14%	1.02%	0.01%	-0.06%	0.04%	0.78%	-0.76%	0.82%	0.55%
Net Income	-4.36M	32.04M	8.25M	6.2M	23.83M	5.2M	25.93M	13.49M	15.89M	13.49M
Depreciation & Amortization	10K	-3.11M	-1.93M	487K	4.95M	12.09M	4.06M	2.83M	2.91M	1.81M
Deferred Taxes	3.27M	-21.64M	15.74M	31K	-7.1M	-1.71M	6.95M	-3.94M	-1.29M	4.81M
Other Non-Cash Items	12.45M	2.94M	-3.44M	14.3M	-1.52M	1.75M	-4.29M	-1.2M	-2.17M	1.46M
Working Capital Changes	-798K	-959K	533K	-1.65M	-2.15M	1.21M	479K	-3.47M	-966K	534K
Cash from Investing+	-18.88M	-21.05M	-12.12M	-28.13M	-26.72M	-35.17M	25.76M	-43.55M	-48.95M	-10.13M
Purchase of Investments	0	0	0	0	-159K	0	0	0	0	0
Sale/Maturity of Investments	80K	1000K	438K	290K	263K	115K	1000K	1000K	1000K	601K
Net Investment Activity	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	-19.72M	0	0	0	0	0
Other Investing	-18.91M	-22.5M	-12.56M	-28.42M	-7.06M	-31.34M	24.84M	-47.45M	-62.39M	-10.6M
Cash from Financing+	-3.77M	-3.7M	-8.96M	-1.83M	-883K	7.75M	-20.2M	-1.36M	33.14M	-12.22M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-213K	0	0	-1.36M	-883K	-2.01M	-368K	-1.14M	-6.33M	-6.01M
Stock Issued	17K	0	0	0	0	0	0	0	0	0
Net Stock Activity	-	-	-	-	-	-	-	-	-	-
Debt Issuance (Net)	0	0	0	0	0	1000K	-1000K	1000K	1000K	-1000K
Other Financing	-3.58M	-3.7M	-8.96M	-469K	0	-2M	-8.08M	-2.66M	-3.41M	-93K
Net Change in Cash+	-11.44M	-15.11M	-1.63M	-10.33M	-9.07M	-8.15M	39.85M	-36.71M	-920K	691K
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	58.73M	47.29M	32.18M	30.56M	20.23M	11.16M	3.01M	42.86M	6.16M	5.24M
Cash at End	47.29M	32.18M	30.56M	20.23M	11.16M	3.01M	42.86M	6.16M	5.24M	5.93M
Interest Paid	0	0	0	0	0	137K	110K	268K	1.35M	3.08M
Income Taxes Paid	0	0	0	0	0	0	0	0	0	0
Free Cash Flow+	11.16M	9.64M	19.46M	19.63M	18.49M	15.33M	33.22M	7.91M	14.39M	22.91M
FCF Growth %	1.18%	-0.14%	1.02%	0.01%	-0.06%	-0.17%	1.17%	-0.76%	0.82%	0.59%

Banking Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-4.02%	14.91%	1.58%	3.17%	10.6%	2.18%	10.21%	4.93%	5.67%	4.74%
Return on Assets (ROA)	-4%	14.84%	1.46%	2.91%	10.14%	1.97%	9.32%	4.63%	5.01%	4.05%
Net Interest Margin	-0.21%	7.58%	0%	-0.07%	-0.13%	-0.17%	-0.13%	-0.11%	-0.55%	-1.41%
Efficiency Ratio	60.64%	20.05%	10.94%	-	47.46%	61.66%	31.64%	59.21%	52.1%	69.35%
Equity / Assets	99.42%	99.58%	84.52%	98.79%	92.99%	87.81%	94.54%	93.43%	83.86%	86.89%
Book Value / Share	13.82	15.98	13.6	16.32	18.32	18.7	20.82	21.73	22.08	23.19
NII Growth	33.04%	4257.22%	-100%	-	-111.25%	-34.62%	17.8%	9.09%	-443.82%	-153.38%

Frequently Asked Questions

Valuation & Price

SWK Holdings Corporation (SWKH) has a price-to-earnings (P/E) ratio of 16.2x. This is roughly in line with market averages.

Growth & Financials

SWK Holdings Corporation (SWKH) grew revenue by 19.1% over the past year. This is strong growth.

Yes, SWK Holdings Corporation (SWKH) is profitable, generating $22.7M in net income for fiscal year 2024 (30.0% net margin).

Dividend & Returns

SWK Holdings Corporation (SWKH) has a return on equity (ROE) of 4.7%. This is below average, suggesting room for improvement.

Industry Metrics

SWK Holdings Corporation (SWKH) has a net interest margin (NIM) of -1.4%. NIM has been under pressure due to interest rate environment.

SWK Holdings Corporation (SWKH) has an efficiency ratio of 69.3%. This is higher than peers, suggesting room for cost optimization.

US Stock Screener

...